XML 32 R23.htm IDEA: XBRL DOCUMENT v3.22.2
Note 17 - Earnings Per Share
6 Months Ended
May 31, 2022
Notes to Financial Statements  
Earnings Per Share [Text Block]

17.

EARNINGS PER SHARE

 

For the three and six months ended May 31, 2022, the Company recorded net loss available to common shareholders. As such, because the dilution from potential common shares was antidilutive, the Company used basic weighted-average common shares outstanding, rather than diluted weighted-average common shares outstanding when calculating diluted loss per share for the three and six months ended May 31, 2022.  Stock options and RSUs that could potentially dilute basic earnings per share ("EPS") in the future that were not included in the compilation of diluted loss per share were as follows:

 

  

For the Three Months Ended

  

For the Six Months Ended

 
  

May 31,

  

May 31,

 
  

2022

  

2022

 

Stock Options

  320,533   320,533 

Restricted stock units

  787,122   787,122 

Total

  1,107,655   1,107,655 

 

For the three and six months ended  May 31, 2021, the Company recorded net income.  As such, the Company used diluted weighted-average common shares outstanding when calculating diluted income per share for the three and six months ended May 31, 2021.  Warrants, stock options, and RSUs that could potentially dilute basic EPS in the future are included in the computation of diluted income per share. 

 

The following table sets forth the allocation of net loss for the three and six months ended May 31, 2022 and 2021, respectively:

 

  

For the Three Months Ended

  

For the Six Months Ended

 
  

May 31,

  

May 31,

 
  

2022

  

2021

  

2022

  

2021

 

Net income (loss)

 $(2,996) $2,037  $(6,217) $1,765 

Preferred stock dividends

     (1,043)     (1,043)

Net loss available to common shareholders

 $(2,996) $994  $(6,217) $722 
                 

Weighted-average number of shares used in computing net loss per share, basic

  23,097,150   17,800,749   23,443,766   16,359,496 

Net income (loss) per share -- basic

 $(0.13) $0.06  $(0.27) $0.04 

Weighted-average number of shares used in computing net income per share, diluted

  23,097,150   18,989,231   23,443,766   17,604,131 

Net income per share -- diluted

 $(0.13) $0.05  $(0.27) $0.04 

 

For the three and six months ended May 31, 2022, the Company’s potential dilutive securities, which may include stock options, unvested restricted stock units, convertible preferred stock, and outstanding warrants to purchase shares of common stock, have been excluded from the computation of diluted net loss per share as the effect would be to reduce the net loss per share. Therefore, the weighted-average number of common shares outstanding used to calculate both basic and diluted net loss per share attributable to common stockholders is the same. 

 

The following table reconciles the weighted-average common shares outstanding used in the calculation of basic EPS to the weighted-average common shares outstanding used in the calculation of diluted EPS for the three and six months ended May 31, 2022 and 2021:

 

 

  

For the Three Months Ended

  

For the Six Months Ended

 
  

May 31,

  

May 31,

 
  

2022

  

2021

  

2022

  

2021

 

Weighted-average common shares outstanding- basic

  23,097,150   17,800,749   23,443,766   16,359,496 

Assumed conversion of:

                

Dilutive Stock Options

     597,214      600,918 

Dilutive Warrants

     304,883      399,332 

Dilutive RSUs

     286,385      244,385 

Weighted-average common share outstanding- diluted

  23,097,150   18,989,231   23,443,766   17,604,131 

 

1,155,000 RSUs outstanding during the three and six months ended May 31, 2021 were not included in the computation of diluted EPS because they are contingently issuable shares.  

 

The following potential common shares, presented based on amounts outstanding at each period end, were excluded from the calculation of diluted net loss per share attributable to common stockholders for the periods indicated because including them would have had an anti-dilutive effect:

 

  

For the Three Months Ended

  

For the Six Months Ended

 
  

May 31, 2021

  

May 31, 2021

 

Antidilutive securities:

       

Options

  638,000   518,000 

RSUs

  50,000   68,493 

Total antidilutive securities

  688,000   586,493